NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 7c9eafb9-9ce1-4b28-900c-8fcb4b23424e | 2026-06-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 4f70f907-08d5-4c2e-a4be-32c6124faa7b | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Mylan Pharmaceuticals Inc. | 115a84c2-0126-4dd7-816e-1873875f1e49 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Voriconazole | VORICONAZOLE | Mylan Pharmaceuticals Inc. | b8de04a0-238d-4e0b-b0d9-7f7878b149d4 | 2026-06-02 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Hydrocortisone | HYDROCORTISONE | Mylan Pharmaceuticals Inc. | bc751403-94f2-4f9d-b533-cf6186a40ceb | 2026-05-25 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE | Mylan Pharmaceuticals Inc. | efbde0f6-b848-4664-b741-c6c630e66108 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Mylan Pharmaceuticals Inc. | 2627eb11-06bf-4a45-9172-094468e3ca07 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| phenelzine sulfate | PHENELZINE SULFATE | Mylan Pharmaceuticals Inc. | fa041652-fdde-4794-a8d2-279dd309e075 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | d4243a76-516c-417e-80ba-444a21ecc688 | 2026-05-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Methotrexate | METHOTREXATE | Mylan Pharmaceuticals Inc. | 70c09984-2b36-424f-8b27-3fd0cd4e833d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Pharmaceuticals Inc. | aa5028d6-fd0a-4cf1-b708-c93bb2a7c76a | 2026-04-24 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Abiraterone Acetate | ABIRATERONE ACETATE | Mylan Pharmaceuticals Inc. | fe02db79-fa04-441f-b514-70bd74af6624 | 2026-04-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Meclofenamate Sodium | MECLOFENAMATE SODIUM | Mylan Pharmaceuticals Inc. | 96f19af4-de8f-4fd7-90d8-55fe6ebdd81d | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Difluprednate | DIFLUPREDNATE | Mylan Pharmaceuticals Inc. | 4a3b2649-ee3d-4648-91c8-912a8ba2e73c | 2026-04-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Clozapine | CLOZAPINE | Mylan Pharmaceuticals Inc. | 883b5d43-0339-7dc1-f775-93791fb9b978 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Chlorthalidone | CHLORTHALIDONE | Mylan Pharmaceuticals Inc. | 15dd224a-87ad-48dc-80b1-e8382a452c4c | 2026-04-02 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Fluconazole | FLUCONAZOLE | Mylan Pharmaceuticals Inc. | 737e0fac-a2d2-4053-a0d7-edbfb6248f69 | 2026-04-02 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sirolimus | SIROLIMUS | Mylan Pharmaceuticals Inc. | 5908cd1a-fc5a-462f-99ed-1d8983e253c9 | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Sorafenib Tosylate | SORAFENIB | Mylan Pharmaceuticals Inc. | b7919013-1511-44f0-a759-3fa78a9fa178 | 2026-03-18 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Disopyramide Phosphate | DISOPYRAMIDE PHOSPHATE | Mylan Pharmaceuticals Inc. | 31e79459-107f-4d69-a163-90014f1c4772 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.